TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Faron Pharmaceuticals Oy
Closing information (x1000 SEK)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
11,031
|
4,750
|
8,621 |
Financial expenses |
3,454
|
2,841
|
1,389 |
Earnings before taxes |
-88,197
|
-56,144
|
-12,798 |
Total assets |
165,383
|
135,390
|
36,245 |
Current assets |
109,809
|
101,106
|
2,303 |
Current liabilities |
41,807
|
20,070
|
15,815 |
Equity capital |
104,117
|
102,111
|
-6,366 |
- share capital |
25,745
|
24,582
|
25,606 |
Employees (average) |
10
|
6
|
5 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
63.0%
|
75.4%
|
-17.6% |
Turnover per employee |
1,103
|
792
|
1,724 |
Profit as a percentage of turnover |
-799.5%
|
-1182.0%
|
-148.5% |
Return on assets (ROA) |
-51.2%
|
-39.4%
|
-31.5% |
Current ratio |
262.7%
|
503.8%
|
14.6% |
Return on equity (ROE) |
-84.7%
|
-55.0%
|
201.0% |
Change turnover |
6,056
|
-3,526 | |
Change turnover % |
122%
|
-43% | |
Chg. No. of employees |
4
|
1 | |
Chg. No. of employees % |
67%
|
20% |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.